[Beta-adrenolytic drugs, coronary flow and pitressin-inducdd electroencephalgraphic changes].
D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity; D001921:Brain / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D004569:Electroencephalography; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology*
D000605:Amino Alcohols; D004983:Ethanolamines; D009578:Nitrobenzenes; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents; D014667:Vasopressins; D011433:Propranolol
Beta-adrenolitici, flusso coronarico e modificazioni elettrocardiografiche da pitressina.